Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Radiation, specifically ionizing radiation, is a physical agent capable of depositing enough energy in biological tissues to ionize atoms and molecules, causing direct and indirect molecular damage. This leads to DNA strand breaks, oxidation of proteins, and lipid peroxidation, which can result in cell death, mutations, cancer, or organ dysfunction. High doses of radiation cause acute tissue and organ injury (deterministic effects), while lower doses increase the probability of stochastic effects such as cancer and heritable mutations. Radiation interacts predominantly through the generation of free radicals, especially via the radiolysis of cellular water, initiating cascades of oxidative damage. It impacts rapidly dividing cells more severely and is used therapeutically in controlled doses for cancer treatment (radiotherapy). However, it is not a molecular drug target itself but a method of physical intervention or environmental hazard[1][3][5][7].
DNA damage (double- and single-strand breaks), Generation of reactive oxygen species (ROS), Lipid peroxidation, Protein modification, Induction of apoptosis, necrosis, or senescence[1][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Radiation.